Atlas Trials

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Clinical trial NCT00718159 · COMPLETED

Trial details

NCT number
NCT00718159
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaEssential Thrombocythemia
Start date
2008-08-01
Primary completion
2011-12-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.